In the fight against COVID-19, PIMS Hydroxychloroquine (subsidiary of PureIMS) – together with (among others) the University of Groningen, UMCG and IMDS – is working feverishly on inhaled hydroxychloroquine. Following pulmonary administration, we expect a much greater effect of the drug with a lower chance of side effects, because it is administered directly to the […]

In a joint effort with UMCG, University of Groningen and several international partners, PureIMS is actively battling the COVID-19 pandemic by repurposing hydroxychloroquine for pulmonary administration. A first in man trial with Hydroxychloroquine Cyclops™ is in preparation. Nevertheless, it will take months if not longer before this product will become available, if proven effective. We are […]

The Cyclops™ pre-loaded disposable dry powder inhaler is a product of TopDutch’s life science & health industry and mentioned as an example of the TopDutch pioneering and collaborating mentality! More info

Carduso Capital invests in PIMS-E, a Spin-off company of the University of Groningen that aims to develop an epinephrine dry powder inhaler as alternative to Epipen™. More info